195 related articles for article (PubMed ID: 32269725)
1. Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.
Xiao H; Huang X; Wang S; Liu Z; Dong R; Song D; Dai H
Am J Transl Res; 2020; 12(3):940-949. PubMed ID: 32269725
[TBL] [Abstract][Full Text] [Related]
2. [Metformin protects against bleomycin-induced pulmonary fibrosis in mice].
Xiao HJ; Huang XX; Liu Z; Dong R; Song DY; Zhang X; Wang SY; Dai HP
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1951-1955. PubMed ID: 29996289
[No Abstract] [Full Text] [Related]
3. Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice.
Liu N; Song Y; Liu T; Wang H; Yu N; Ma H
Clin Respir J; 2024 Jan; 18(1):e13731. PubMed ID: 38286745
[TBL] [Abstract][Full Text] [Related]
4. Ouabain ameliorates bleomycin induced pulmonary fibrosis by inhibiting proliferation and promoting apoptosis of lung fibroblasts.
Li B; Huang X; Liu Z; Xu X; Xiao H; Zhang X; Dai H; Wang C
Am J Transl Res; 2018; 10(9):2967-2974. PubMed ID: 30323883
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
6. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms.
Gamad N; Malik S; Suchal K; Vasisht S; Tomar A; Arava S; Arya DS; Bhatia J
Biomed Pharmacother; 2018 Jan; 97():1544-1553. PubMed ID: 29793317
[TBL] [Abstract][Full Text] [Related]
7. Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice.
Choi SM; Jang AH; Kim H; Lee KH; Kim YW
J Korean Med Sci; 2016 Sep; 31(9):1419-25. PubMed ID: 27510385
[TBL] [Abstract][Full Text] [Related]
8. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
Zhou XM; Wang GL; Wang XB; Liu L; Zhang Q; Yin Y; Wang QY; Kang J; Hou G
Front Pharmacol; 2017; 8():904. PubMed ID: 29311918
[No Abstract] [Full Text] [Related]
9. DAB2 promotes pulmonary fibrosis and may act as an intermediate between IGF‑1R and PI3K/AKT signaling pathways.
Liang CL; Li XL; Quan XJ; Zhang L
Exp Ther Med; 2023 Apr; 25(4):183. PubMed ID: 37021069
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
11. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
Nie Y; Yu K; Li B; Hu Y; Zhang H; Xin R; Xiong Y; Zhao P; Chai G
J Pharmacol Sci; 2019 Apr; 139(4):377-384. PubMed ID: 30928090
[TBL] [Abstract][Full Text] [Related]
12. Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1/Th2 shift.
Xing XY; Qiang WJ; Bao JL; Yang RC; Hou J; Tao K; Meng ZQ; Zhang JH; Zhang AJ; Sun XB
Chin Herb Med; 2020 Jul; 12(3):273-280. PubMed ID: 36119009
[TBL] [Abstract][Full Text] [Related]
13. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
14. Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway.
Huang X; He Y; Chen Y; Wu P; Gui D; Cai H; Chen A; Chen M; Dai C; Yao D; Wang L
BMC Pulm Med; 2016 Sep; 16(1):132. PubMed ID: 27658704
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis.
Kim TH; Kim SH; Seo JY; Chung H; Kwak HJ; Lee SK; Yoon HJ; Shin DH; Park SS; Sohn JW
Tohoku J Exp Med; 2011 Jan; 223(1):45-54. PubMed ID: 21212602
[TBL] [Abstract][Full Text] [Related]
16. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
17. Role of insulin like growth factor axis in the bleomycin induced lung injury in rats.
Kotarkonda LK; Kulshrestha R; Ravi K
Exp Mol Pathol; 2017 Feb; 102(1):86-96. PubMed ID: 28077319
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem-cells Inhibit Experimental Bleomycin-induced Pulmonary Fibrosis through Regulation of the Insulin-like Growth Factor Signaling.
Bayati P; Taherian M; Assarehzadegan MA; Soleimani M; Poormoghim H; Mojtabavi N
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):263-272. PubMed ID: 35822677
[TBL] [Abstract][Full Text] [Related]
19. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
